Purdue Pharma OxyContin
Executive Summary
About 180 sales reps are being retrained "with the presence of [Drug Enforcement Administration] leadership to make sure their...marketing to the medical community makes clear that this drug is only to be used in very isolated incidences," Attorney General of Virginia Mark Earley told a May 14 press briefing. Purdue Pharma's ongoing initiatives to curb diversion and abuse of the drug include temporary suspension of the 160 mg tablet. The National Association of Attorneys General Prescription Drug Abuse Task Force was recently formed to coordinate efforts aimed at preventing OxyContin abuse
|
About 180 sales reps are being retrained "with the presence of [Drug Enforcement Administration] leadership to make sure their...marketing to the medical community makes clear that this drug is only to be used in very isolated incidences," Attorney General of Virginia Mark Earley told a May 14 press briefing. Purdue Pharma's ongoing initiatives to curb diversion and abuse of the drug include temporary suspension of the 160 mg tablet. The National Association of Attorneys General Prescription Drug Abuse Task Force was recently formed to coordinate efforts aimed at preventing OxyContin abuse. |